U.S. Perfusion Systems Market Size & Outlook, 2023-2030
U.S. perfusion systems market, 2018-2030 (US$M)
Related Markets
U.S. perfusion systems market highlights
- The U.S. perfusion systems market generated a revenue of USD 290.1 million in 2023 and is expected to reach USD 396.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.6% from 2024 to 2030.
- In terms of segment, cardiopulmonary perfusion system was the largest revenue generating application in 2023.
- Cardiopulmonary Perfusion System is the most lucrative application segment registering the fastest growth during the forecast period.
Perfusion systems market data book summary
| Market revenue in 2023 | USD 290.1 million |
| Market revenue in 2030 | USD 396.8 million |
| Growth rate | 4.6% (CAGR from 2023 to 2030) |
| Largest segment | Cardiopulmonary perfusion system |
| Fastest growing segment | Cardiopulmonary Perfusion System |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
| Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
Other key industry trends
- In terms of revenue, U.S. accounted for 25.9% of the global perfusion systems market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. perfusion systems market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 396.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Perfusion Systems Market Scope
Perfusion Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. perfusion systems market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to perfusion systems market will help companies and investors design strategic landscapes.
Cardiopulmonary perfusion system was the largest segment with a revenue share of 43.88% in 2023. Horizon Databook has segmented the U.S. perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
The increase in the prevalence of chronic diseases and the resulting rise in the number of cardiovascular surgeries in the U.S. are anticipated to propel the demand for perfusion systems. Approximately 150 million U.S. individuals suffer from at least one chronic illness, which frequently requires surgery, according to CDC data.
Respiratory problems and heart ailments significantly contribute to the rising number of surgical procedures. There is a fierce rivalry between major players in the market to increase their share. Leading competitors include Medtronic, LivaNova PLC, and Fresenius Medical Care AG.
These players are significantly investing in R&D to introduce cutting-edge products. For instance, Fresenius Medical Care AG’s Novalung helps treat patients with acute respiratory failure, making it a significant player in the market.
Reasons to subscribe to U.S. perfusion systems market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. perfusion systems market databook
-
Our clientele includes a mix of perfusion systems market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. perfusion systems market , including forecasts for subscribers. This country databook contains high-level insights into U.S. perfusion systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. perfusion systems market size, by application, 2018-2030 (US$M)
U.S. Perfusion Systems Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
